Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Siam Bioscience Readies to Commercialize Monoclonal Antibodies

Filed Under: Industry, Pharma Tagged With: , , , , , , , ,

Thai biopharmaceuticals firm Siam Bioscience Co. Ltd. is planning to begin commercial business operations for monoclonal antibodies in 2019. As…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

JSR Pursues New Developments in Life Sciences Business
JSR Pursues New Developments in Life Sciences Business
Thai Chemical and Material Producers Pursue Continued Growth by Investing in Indonesia
Thai Chemical and Material Producers Pursue Continued Growth…
SCG Readies to Take Chemicals Subsidiary Public
SCG Readies to Take Chemicals Subsidiary Public
SCG Looks to Commercialize Chemical Recycling
SCG Looks to Commercialize Chemical Recycling
Tosoh Acquires US Venture for Continuous Biopharma Production
Tosoh Acquires US Venture for Continuous Biopharma…
SCG Sets 2025 Sales Target for Recycled and Bio-Based Resins
SCG Sets 2025 Sales Target for Recycled and Bio-Based Resins